The effect of prescription versus not prescription of the prophylactic antibiotic on clinical outcomes in newborn with transient tachypnea
Phase 2
- Conditions
- Transient tachypnea.Transient tachypnoea of newborn
- Registration Number
- IRCT201609049014N114
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Neonate with gestational age of 34 to 41 weeks; respiratory distress for at least 4 hours.
Exclusion criteria: prenatal or perinatal infection; congenital anomalies; disposal of meconium during delivery; Apgar score of 7 or lower; pneumonia; indication of mechanical ventilation; signs of primary septicemia; need for additional oxygen with pressure more than 40%.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing the incidence of pneumonia. Timepoint: on the first, second, and third days after intervention. Method of measurement: through physical examination.;Assessing the signs of septicemia. Timepoint: on the first, second, and third days after intervention. Method of measurement: through physical examination.;Assessing the incidence of death. Timepoint: on the first, second, and third day after intervention. Method of measurement: through physical examination.
- Secondary Outcome Measures
Name Time Method Assessing duration of hospitalization. Timepoint: based on medical record. Method of measurement: at discharge.;Assessing blood culture. Timepoint: on the first, second, and third days after intervention. Method of measurement: through laboratory test.;Assessing adverse effect of medications such as renal failure. Timepoint: on the first, second, and third days after intervention. Method of measurement: through laboratory test.